Eleva has initiated dosing in its Phase I trial of its recombinant human complement Factor H (CPV-104) programme, aimed at ...

Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced today the first dosing in its Phase 1 clinical study ...

Amsbio, in collaboration with Nordmark Biochemicals, has broadened access to high-purity collagenase and neutral protease ...

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to ...

Hyundai’s next Ioniq car is incoming► New Ioniq 2 is next up for reveal► Concept car will be at 2025 Munich show When a car maker has a successful model line that includes the numbers 5, 6 and 9, it’s ...

EVE Health Group (ASX: EVE) has submitted the first commercial purchase order for its proprietary gummy-format pharmaceutical ...

Hong Kong-traded shares in Shanghai Fosun Pharmaceutical – which owns more than 60% of Shanghai Henlius – have trended ...

Law-abiding pedestrians wait for the green woman kicking a soccer ball before they cross the road during the Women’s European ...

Russia fired more than 100 drones at civilian areas of Ukraine overnight, authorities said Monday, as the Kremlin dismissed ...

Latest news, features and opinion on the European Union, covering the United Kingdom's Brexit decision, the euro and the trading bloc's relationship with China and the United States.